Related Experiment Video

Updated: Aug 13, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Congenital hypothyroidism detected by neonatal screening: relationship between biochemical severity and early

D B Grant1, I Smith, P W Fuggle

  • 1MRC Hypothyroid Register, Institute of Child Health, London.

Archives of Disease in Childhood
|January 1, 1992
PubMed

Insights

Severe congenital hypothyroidism in infants, identified by neonatal screening, is linked to specific clinical signs and developmental delays. Lower thyroxine levels correlate with more severe symptoms and thyroid agenesis.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Neonatal screening

Background:

  • Congenital hypothyroidism (CH) is a common neonatal endocrine disorder.
  • Early diagnosis and treatment are crucial to prevent developmental impairments.

Purpose of the Study:

  • To evaluate the relationship between biochemical severity of CH and clinical/radiographic findings at diagnosis.
  • To compare outcomes in CH infants with a normal population.

Main Methods:

  • Retrospective analysis of 449 infants with CH identified via neonatal screening (1982-4).
  • Assessment of plasma thyroxine levels, clinical signs, radiographic bone maturation, and thyroid imaging.
  • Comparison with a control group of 36,727 infants born in 1988.

Main Results:

  • Infants with thyroxine ≤ 30 nmol/l showed higher rates of prolonged jaundice, feeding difficulties, lethargy, umbilical hernia, macroglossia, delayed bone maturation, and thyroid agenesis.
  • Ectopic or hypoplastic thyroid glands were more frequent in infants with thyroxine > 30 nmol/l.
  • Perinatal illness and congenital malformations were more common in infants with lower thyroxine levels.

Conclusions:

  • Biochemical severity of CH significantly correlates with specific clinical manifestations and thyroid gland morphology.
  • Neonatal screening effectively identifies CH, but severity influences presentation and associated complications.

More Related Videos

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats07:36

Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats

Published on: November 20, 2015

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions05:41

Synchronous Triplanar Reconstruction Integrated with Color Doppler Mapping for Precise and Rapid Localization of Thyroid Lesions

Published on: February 9, 2024

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis01:25

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...